Your institution may have access to this item. Find your institution then sign in to continue.
Title
Osimertinib v terapii pokročilého neskvamózního nemalobuněčného plicního karcinomu.
Authors
Zemanová, Petra; Zemanová, Milada
Abstract
The case report describes a 76-year-old patient diagnosed with metastatic non-small cell lung adenocarcinoma. The patient was treated with osimertinib, an EGFR tyrosine kinase inhibitor, after detecting the EGFR T790M mutation.